Shandong Sanyuan Biotechnology Co.Ltd. (301206) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shandong Sanyuan Biotechnology Co.Ltd. (301206) has a cash flow conversion efficiency ratio of 0.006x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥24.79 Million ≈ $3.63 Million USD) by net assets (CN¥4.31 Billion ≈ $631.41 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Shandong Sanyuan Biotechnology Co.Ltd. - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Shandong Sanyuan Biotechnology Co.Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Shandong Sanyuan Biotechnology Co.Ltd. carry for a breakdown of total debt and financial obligations.
Shandong Sanyuan Biotechnology Co.Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shandong Sanyuan Biotechnology Co.Ltd. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Johns LYNG Group Ltd
AU:JLG
|
0.096x |
|
Costar Group Co Ltd
SHE:002189
|
0.004x |
|
Shanghai Maling Aquarius Co Ltd
SHG:600073
|
0.129x |
|
Tae Kwang Corporation
KQ:023160
|
0.005x |
|
RIAMB (Beijing) Tech Dvlp Co
SHG:603082
|
0.022x |
|
Suzhou Longway Electronic Machinery Co. Ltd. A
SHE:301202
|
N/A |
|
Shandong Xiantan Co Ltd
SHE:002746
|
0.054x |
|
Time Publishing and Media Co Ltd Class A
SHG:600551
|
-0.006x |
Annual Cash Flow Conversion Efficiency for Shandong Sanyuan Biotechnology Co.Ltd. (2013–2024)
The table below shows the annual cash flow conversion efficiency of Shandong Sanyuan Biotechnology Co.Ltd. from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see Shandong Sanyuan Biotechnology Co.Ltd. market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥4.49 Billion ≈ $657.20 Million |
CN¥-13.65 Million ≈ $-2.00 Million |
-0.003x | -124.06% |
| 2023-12-31 | CN¥4.54 Billion ≈ $664.06 Million |
CN¥57.31 Million ≈ $8.39 Million |
0.013x | -30.75% |
| 2022-12-31 | CN¥4.62 Billion ≈ $676.16 Million |
CN¥84.26 Million ≈ $12.33 Million |
0.018x | -97.03% |
| 2021-12-31 | CN¥1.05 Billion ≈ $152.96 Million |
CN¥642.08 Million ≈ $93.96 Million |
0.614x | +44.09% |
| 2020-12-31 | CN¥509.91 Million ≈ $74.62 Million |
CN¥217.37 Million ≈ $31.81 Million |
0.426x | -0.54% |
| 2019-12-31 | CN¥348.15 Million ≈ $50.95 Million |
CN¥149.21 Million ≈ $21.83 Million |
0.429x | +17.53% |
| 2018-12-31 | CN¥179.52 Million ≈ $26.27 Million |
CN¥65.46 Million ≈ $9.58 Million |
0.365x | +108.57% |
| 2017-12-31 | CN¥115.81 Million ≈ $16.95 Million |
CN¥20.25 Million ≈ $2.96 Million |
0.175x | -34.01% |
| 2016-12-31 | CN¥86.64 Million ≈ $12.68 Million |
CN¥22.96 Million ≈ $3.36 Million |
0.265x | +17.99% |
| 2015-12-31 | CN¥42.30 Million ≈ $6.19 Million |
CN¥9.50 Million ≈ $1.39 Million |
0.225x | +86.87% |
| 2014-12-31 | CN¥26.60 Million ≈ $3.89 Million |
CN¥3.20 Million ≈ $467.64K |
0.120x | -19.43% |
| 2013-12-31 | CN¥26.08 Million ≈ $3.82 Million |
CN¥3.89 Million ≈ $569.13K |
0.149x | -- |
About Shandong Sanyuan Biotechnology Co.Ltd.
Shandong Sanyuan Biotechnology Co.,Ltd. engages in the research and development, production, and sale of erythritol and compound sugar products in China. Its products are used in table sugar, flavored sugar, and beverages; candy and chocolate food; baked food; health food; medical supplies; cosmetic products; chemical products; and other applications. The company exports its products to Europe, t… Read more